准Rab7-Rilp介导的微脂会减轻糖尿病心肌病的脂质毒性
Jiahan Ke1, Jianan Pan1, Hao Lin1
1Department of Cardiology, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, 200001, China.
概括
糖尿病心肌病症涉及心脏细胞中的脂质积累. 准Rab7-Rilp通路可增强脂质分解,并可能治疗这种疾病.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 糖尿病心肌病 (DbCM) 是糖尿病患者的心脏病,以腹功能障碍和心力衰竭为特征.
- 脂质滴积累和随后心肌细胞中的脂毒性是DbCM的关键驱动因素.
- 目前对DbCM的治疗方法有限,需要探索新的治疗点.
研究的目的:
- 调查脂质在DbCM中的作用,并确定参与脂质滴滴降解的关键分子通路.
- 探索针对Rab7-Rilp途径在DbCM治疗干预的潜力.
主要方法:
- 在DbCM和对照心脏中对脂质路径 (微脂质与宏脂质) 的比较分析.
- RNA测序和基因操纵 (Rab7-CKO小鼠) 来识别脂质的关键调节者.
- 生物化学测定证实Rab7酸化及其与Rilp的相互作用.
- 在DbCM小鼠模型中使用ML-098对Rab7的药理活性.
主要成果:
- 脂质滴滴积累和脂毒性在DbCM心脏中得到证实.
- 在DbCM中,微脂质的途径被激活,而不是宏脂质.
- Rab7被确定为微脂质的关键调节器,其在氨酸183的酸化促进了Rilp招募和溶酶体脂质降解.
- 在DbCM小鼠中,Rab7与ML-098的药理激活增加了Rilp水平,并改善了心脏功能.
结论:
- Rab7-Rilp介导的微脂质是DbCM中降解脂质滴的关键途径.
- 这一途径代表了减轻脂质毒性和恢复糖尿病心肌病中心脏功能的有希望的治疗标.
相关概念视频
01:28Insulin: The Receptor and Signaling Pathways
6.0K
Insulin action is mediated through a receptor tyrosine kinase, akin to the IGF-1 receptor. The number of receptors per cell varies significantly, from 40 on erythrocytes to 300,000 on adipocytes and hepatocytes. The insulin receptor consists of linked α/β subunit dimers, forming a heterotetramer glycoprotein with two extracellular α subunits and two β subunits spanning the membrane. The α subunits inhibit the inherent tyrosine kinase activity of the β subunits, but...
6.0K
01:27Diabetic Retinopathy
55
DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
55
01:28Diabetic Nephropathy
32
Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration...
32
01:22Diabetic Neuropathy
59
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
59